Kelley-Ross Compounding Pharmacy

Form 483 issued September 23, 2020 · Sea ttle, Washington

Inspection
Sep 8 – Sep 23, 2020
Observations
5
Pages
4
FEI number
3013436443

In short: On September 23, 2020, FDA issued a Form 483 with 5 observations to Kelley-Ross Compounding Pharmacy in Sea ttle, Washington (FEI 3013436443) after an inspection that ran Sep 8 – Sep 23, 2020. The investigator was Christopher R. Czajka.

What FDA observed

Preview: the opening words of each observation
  1. 01
    FDCA 501(a)(2)(A)

    Materials or supplies were not disinfected prior to entering…

  2. 02
    FDCA 501(a)(2)(A)

    Your facility design allowed the influx of poor quality air into…

  3. 03
    FDCA 501(a)(2)(A)

    The ISO 5 classifi ed aseptic processing areas had difficult to clean and visibly…

  4. 04
    FDCA 501(a)(2)(A)

    Personnel donned gowning apparel improperly, in a way that may have caused the gowning…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Kelley-Ross Compounding Pharmacy?

FDA listed 5 observations on this Form 483. The opening words of each observation are shown on this page.

Who inspected Kelley-Ross Compounding Pharmacy?

Christopher R. Czajka is named on this Form 483, for the inspection of Sep 8 – Sep 23, 2020. Each investigator has a profile showing what they cite most.

When was Kelley-Ross Compounding Pharmacy inspected by FDA?

The inspection ran Sep 8 – Sep 23, 2020, and the Form 483 is dated September 23, 2020.

How do I get the full Form 483 for Kelley-Ross Compounding Pharmacy?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free